Oral absorption and clearance of partially depolymerized fucosyl chondroitin sulfate from sea cucumber

Thrombosis Research

Volumn 93, Issue 3, 1999, Pages 129-135

  Imanari, Toshio ^a   Washio, Yukio ^a   Huang, Yong ^a   Toyoda, Hidenao ^a   Suzuki, Atsushi ^a   Toida, Toshihiko ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Fucosyl chondroitin sulfate; Oral administration; Pharmacokinetics; Sea cucumber

Indexed keywords

CHONDROITIN SULFATE; DEPOLYMERIZED HOLOTHURIAN GLYCOSAMINOGLYCAN; GLYCOSAMINOGLYCAN; HOLOTHURIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EXCRETION; DRUG ISOLATION; ECHINODERM; GASTROINTESTINAL ABSORPTION; GEL FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

ADMINISTRATION, ORAL; ANIMALS; CHONDROITIN SULFATES; DIMERIZATION; FUCOSE; INJECTIONS, INTRAVENOUS; MALE; PLANTS; RATS;

EID: 0033083951     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00171-6     Document Type: Article

References (22)

1. Linhardt R.J., Toida T. Heparin oligosaccharides - New analogs development and applications. Witczak Z.B., Nieforth K.A. Carbohydrates as Drugs. 1997;277-341 Marcel Dekker, New York.
2. Bourin M.C., Lindahl U. Glycosaminoglycans and the regulation of blood coagulation. Biochem J. 289:1993;313-330.
3. Walker A., Gallagher J.T. Structural domains of heparan sulphate for specific recognition of the C-terminal heparin-binding domain of human plasma fibronectin (HEPII). Biochem J. 317:1996;871-877.
4. Lyon M., Deakin J.A., Mizuno K., Nakamura T., Gallagher J.T. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J Biol Chem. 269:1994;11216-11223.
5. Laurent T.C., Fraser J.R. Hyaluronan. FASEB J. 6:1992;2397-2404.
6. Dawes J., McLaren M., Forbes C., Belch J.J.F., Lane D.A., Bray B., McEwen J., Houin G., Gianese F. The pharmacokinetics of dermatan sulphate MF701 in healthy human volunteers. Br J Clin Pharmacol. 32:1991;361-366.
7. Dawes J., Hodson B.A., Pepper D.S. The absorption, clearance and metabolic fate of dermatan sulphate administered to man-studies using a radioiodinated derivative. Thromb Haemost. 62:1989;945-949.
8. Larsen A.K., Lund D.P., Langer R., Folkman J. Oral heparin results in the appearance of heparin fragments in the plasma of rats. Proc Natl Sci USA. 83:1986;2964-2968.
9. Vieira R.P., Mourao A.S. Occurrence of a unique fucose-branched chondroitin sulfate in the body wall of a sea cucumber. J Biol Chem. 263:1988;18176-18183.
10. Vieira R.P., Mulloy B., Mourao P.A. Structure of a fucose-branched chondroitin sulfate from sea cucumber. Evidence for the presence of 3-O-sulfo-beta-D-glucuronosyl residues. J Biol Chem. 266:1991;13530-13536.
11. Li J.Z., Lian E.C. Aggregation of human platelets by acidic mucopolysaccharide extracted from Stichopus japonicus Selenka. Thromb Haemost. 59:1988;435-439.
12. Suzuki N., Kitazato K., Takamatsu J., Saito H. Antithrombotic and anticoagulant activity of depolymerized fragment of the glycosaminoglycan extracted from Stichopus japonicus Selenka. Thromb Haemost. 65:1991;369-373.
13. Nagase H., Enjyoji K., Minamiguchi K., Kitazato K.T., Kitazato K., Saito H., Kato H. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions. Antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin Blood. 85:1995;1527-1534.
14. Jaques L.B. The pharmacology of heparin and heparinoids. Prog Med Chem. 5:1967;139-198.
15. Boneu B., Caranobe C., Saivin S., Dol F., Sie P. Pharmacokinetics of heparin and dermatan sulfate. Clinical implications Lane D.A., Bjork I., Lindahl U. Heparin and Related Polysaccharides. 1992;237-247 Plenum Press, New York.
16. Silvestro L., Lanzarotti E., Marchi E., Gori M., Pescador R., Ferro L., Milani M.R., Da Col R., Coppini A. Human pharmacokinetics of glycosaminoglycans using deuterium-labeled and unlabeled substances. Evidence for oral absorption Semin Thromb Hemost. 20:1994;281-292.
17. Silvestro L, Naggi A, Lanzarotti A, Da Col R, Torri G, Casu B, Pescador R, Baiocchi C, Prino G, Viano I. A novel approach to human pharmacokinetics of glycosaminoglycans using HPLC/ion spray mass spectrometry on deuterium-labeled compounds. International Symposium on Heparin and Related polysaccharides. Uppsala; Abstract 83. 1991.
18. Huang Y., Toyoda H., Koshiishi I., Toida T., Imanari T. Dermination of a depolymerized holothurian glycosaminoglycan in plasma after intravenous administration by postcolumn HPLC. Chem Pharm Bull. 43:1995;2182-2186.
19. Huang Y., Toyoda H., Toida T., Imanari T. Determination of chondroitin sulfates in human whole blood, plasma and blood cells by HPLC. Biomed Chromatogr. 9:1995;102-105.
20. Yoshida K.I., Minami Y., Nemoto H., Numata K., Yamanaka E. Structure of DHG, a depolymerized glycosaminoglycan from sea cucumber, Stichopus japonicus. Tetrahed Lett. 33:1992;4959-4962.
21. Toida T., Toyoda H., Imanari T. High-resolution proton nuclear magnetic resonance studies on chondroitin sulfates. Anal Sci. 9:1993;53-58.
22. Toida T., Yoshida H., Toyoda H., Koshiishi I., Imanari T., Hileman R.E., Smith A.E., Linhardt R.J. Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. Biochem J. 322:1997;499-506.